USA - NYSE:ARDT - US03980N1072 - Common Stock
The current stock price of ARDT is 14.4 USD. In the past month the price increased by 2.49%. In the past year, price decreased by -12.03%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| HCA | HCA HEALTHCARE INC | 18.42 | 111.52B | ||
| THC | TENET HEALTHCARE CORP | 13.23 | 18.13B | ||
| UHS | UNIVERSAL HEALTH SERVICES-B | 11.02 | 14.59B | ||
| EHC | ENCOMPASS HEALTH CORP | 22.3 | 11.61B | ||
| ENSG | ENSIGN GROUP INC/THE | 28.84 | 10.38B | ||
| SGRY | SURGERY PARTNERS INC | 25.6 | 2.76B | ||
| CON | CONCENTRA GROUP HOLDINGS PAR | 15.72 | 2.48B | ||
| BKD | BROOKDALE SENIOR LIVING INC | N/A | 2.24B | ||
| NHC | NATIONAL HEALTHCARE CORP | 18.95 | 1.97B | ||
| PACS | PACS GROUP INC | 16.21 | 1.91B | ||
| ACHC | ACADIA HEALTHCARE CO INC | 7.53 | 1.80B | ||
| SEM | SELECT MEDICAL HOLDINGS CORP | 15.5 | 1.65B |
Ardent Health, Inc. engages in the provision of healthcare and related services. The company is headquartered in Brentwood, Tennessee and currently employs 19,200 full-time employees. The company went IPO on 2024-07-18. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and approximately 280 sites of care with over 1,800 affiliated providers across six states. The company provides both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. In addition to its 30 acute care hospitals, it operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers (ASCs), urgent care centers, free-standing emergency departments, and diagnostic imaging centers. The company operates a consumer-centric healthcare platform focused on creating relationships with its patients across multiple care settings.
ARDENT HEALTH INC
340 Seven Springs Way, Suite 100
Brentwood TENNESSEE US
Employees: 19200
Phone: 16152963000
Ardent Health, Inc. engages in the provision of healthcare and related services. The company is headquartered in Brentwood, Tennessee and currently employs 19,200 full-time employees. The company went IPO on 2024-07-18. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and approximately 280 sites of care with over 1,800 affiliated providers across six states. The company provides both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. In addition to its 30 acute care hospitals, it operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers (ASCs), urgent care centers, free-standing emergency departments, and diagnostic imaging centers. The company operates a consumer-centric healthcare platform focused on creating relationships with its patients across multiple care settings.
The current stock price of ARDT is 14.4 USD. The price decreased by -0.41% in the last trading session.
ARDT does not pay a dividend.
ARDT has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
18 analysts have analysed ARDT and the average price target is 19.81 USD. This implies a price increase of 37.53% is expected in the next year compared to the current price of 14.4.
The PE ratio for ARDENT HEALTH INC (ARDT) is 8.04. This is based on the reported non-GAAP earnings per share of 1.79 and the current share price of 14.4 USD.
The outstanding short interest for ARDENT HEALTH INC (ARDT) is 2.65% of its float.
ChartMill assigns a technical rating of 7 / 10 to ARDT. When comparing the yearly performance of all stocks, ARDT turns out to be only a medium performer in the overall market: it outperformed 59.45% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to ARDT. ARDT has only an average score on both its financial health and profitability.
Over the last trailing twelve months ARDT reported a non-GAAP Earnings per Share(EPS) of 1.79. The EPS increased by 314.38% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 4.11% | ||
| ROA | 5.07% | ||
| ROE | 20.31% | ||
| Debt/Equity | 0.87 |
18 analysts have analysed ARDT and the average price target is 19.81 USD. This implies a price increase of 37.53% is expected in the next year compared to the current price of 14.4.
For the next year, analysts expect an EPS growth of 52.55% and a revenue growth 8.59% for ARDT